Science 37 Holdings Inc (NAS:SNCE)

$ 5.75 0 (0%) Market Cap: 34.67 Mil Enterprise Value: -21.16 Mil PE Ratio: 0 PB Ratio: 0.66 GF Score: 20/100

Science 37 Holdings Inc Extraordinary Shareholders Meeting Transcript
Nov 29, 2023
Q3 2023 Science 37 Holdings Inc Earnings Call Transcript
Nov 07, 2023

$7.2 (-13.81%)

Earnings
Q2 2023 Science 37 Holdings Inc Earnings Call Transcript
Aug 08, 2023

$5.4 (-2.88%)

Earnings
Q1 2023 Science 37 Holdings Inc Earnings Call Transcript
May 15, 2023

$5 (+4.78%)

Earnings
Science 37 Holdings Inc To Host Business Update Call Transcript
Apr 12, 2023
Science 37 Holdings Inc at Cowen Health Care Conference Transcript
Mar 08, 2023
Q4 2022 Science 37 Holdings Inc Earnings Call Transcript
Mar 06, 2023

$5.48 (-14.33%)

Earnings
Science 37 Holdings Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Dec 01, 2022
Q3 2022 Science 37 Holdings Inc Earnings Call Transcript
Nov 11, 2022

$16.99 (-32.06%)

Earnings
Science 37 Holdings Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 13, 2022
Q2 2022 Science 37 Holdings Inc Earnings Call Transcript
Aug 11, 2022

$37.2 (-17.70%)

Earnings
Q1 2022 Science 37 Holdings Inc Earnings Call Transcript
May 09, 2022

$74.2 (+4.80%)

Earnings
Q4 2021 Science 37 Holdings Inc Earnings Call Transcript
Mar 22, 2022

$104.8 (-11.78%)

Earnings
Q3 2021 Science 37 Holdings Inc Earnings Call Transcript
Nov 15, 2021

Earnings

Q1 2022 Science 37 Holdings Inc Earnings Call Transcript

May 09, 2022 / 12:00PM GMT

Release Date Price: $74.2 (+4.80%)

Transcript 10-Q8-K

Operator

Good morning, ladies and gentlemen, and welcome to Science 37's earnings conference call for the quarter ended March 31, 2022. (Operator Instructions) As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Caroline Paul of Investor Relations for a few introductory comments.

Caroline Paul

Gilmartin Group LLC - IR

Thank you, and thank you all for participating in today's call. Joining me are David Coman, Chief Executive Officer; and Mike Zaranek, Chief Financial Officer. Earlier today, Science 37 released financial results for the quarter ended March 31, 2022. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon our current estimates and various assumptions

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.